15 results on '"Chudej, Juraj"'
Search Results
2. Real-world effectiveness and safety of daratumumab, bortezomib and dexamethasone in relapsed/refractory multiple myeloma in Slovakia
3. Heparin induced thrombocytopenia and up to date options of treatment - review of literature
4. Inherited thrombophilia in a patient with colorectal carcinoma
5. Scoring systems stratifying the risk of bleeding, thromboembolism in patients with atrial fibrillation and haemorhagic shock of the patient with triple therapy
6. Treatment Outcomes in Patients Treated with Tyrosine Kinase Inhibitors in "Slovak Registry of Chronic Myeloid Leukemia" (CAMELIA SK)
7. Differential impact of bortezomib on HL-60 and K562 cells
8. Endovascular stenting in malignant obstruction of superior vena cava
9. Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications
10. Evaluation of 5‐year imatinib treatment of 458 patients with CP ‐ CML in routine clinical practice and prognostic impact of different BCR ‐ ABL cutoff levels
11. C0173 High levels of von Willebrand factor antigen and procoagulant factor VIII found in multiple myeloma patients are associated with activity status
12. Treatment of Consecutive Patients with Chronic Myeloid Leukemia In the Cooperating Centers From the Slovak Republic After 2000 – A Report From the Population Based CAMELIA Registry
13. Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA Registry
14. The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses – Population Based Analysis of 458 Patients Treated Between 2003–2009.
15. An in vitro testing of chemoresistance in leukaemic patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.